Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
AstraZeneca PLC ADS (NY: AZN)
50.98 USD  UNCHANGED
Official Closing Price  /  Updated: 6:40 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about AstraZeneca PLC ADS
 
< Previous 1 2 3 4 5 6 7 8 9
...
72 73 Next >
Bristol-Myers (BMY), AstraZeneca (AZN) SAVOR-TIMI-53 Misses Primary Efficacy Endpoint in Phase 4
Today 6:20 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8429774 for the full story. Read More
from StreetInsider.com News Articles
UPDATE 1-AstraZeneca, Bristol diabetes drug disappoints in key test
Today 2:55 EDT
LONDON, June 19 (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might... Read More
category companyNews
from Reuters: Company News
AstraZeneca, Bristol diabetes drug fails to show heart benefit
Today 2:15 EDT
LONDON, June 19 (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study. Read More
category companyNews
from Reuters: Company News
The NIH Aims To Develop Drugs That Big Pharma Discarded
June 18, 2013
This morning, the National Institutes of Health awarded $12.7 million to nine academic groups to test potential medicines for diseases including Alzheimer's disease, Duchenne muscular dystrophy, and... Read More
category NYSE:JNJ , NASDAQ:CBST , NYSE:PFE , and 2 more.
from Forbes Real Time
UPDATE 1-AstraZeneca picks site for new global home in Cambridge
June 18, 2013
* Cambridge Biomedical Campus to house new HQ and R&D centre Read More
category companyNews
from Reuters: Company News
AstraZeneca picks its new home in Cambridge next to top hospital
June 18, 2013
LONDON, June 18 (Reuters) - AstraZeneca has chosen a science park in Cambridge, England, next to the world-renowned Addenbrooke's Hospital, as its new $500 million global headquarters and centre of... Read More
category companyNews
from Reuters: Company News
BRIEF-AstraZeneca's MedImmune, NGM Biopharmaceuticals in deal to develop therapies for diabetes and obesity
June 17, 2013
LONDON, June 17 (Reuters) - AstraZeneca PLC : * Medimmune,NGM Biopharmaceuticals announce agreement to discover and develop Read More
category companyNews
from Reuters: Company News
AstraZeneca taps outside experts to screen cancer compounds
June 13, 2013
LONDON, June 14 (Reuters) - British drugmaker AstraZeneca is deepening its collaboration with academia by roping in more outside researchers to help to find new cancer drugs. Read More
category companyNews
from Reuters: Company News
Drugmakers to cooperate in safety review of diabetes drugs
June 12, 2013
NEW YORK, June 12 (Reuters) - Global drugmakers said on Wednesday they would cooperate with an independent review to address concerns of a potential link between widely used diabetes medicines and... Read More
category companyNews
from Reuters: Company News
Astrazeneca, Bristol-Myers Squibb Release Statement to American Diabetes Association
June 12, 2013
Earlier this week, the American Diabetes Association called for manufacturers of incretin-based therapies to make patient-level data available from clinical trials for an independent analysis of... Read More
category AZN , Benzinga , News , and 1 more.
from Latest Articles from Benzinga.com
Amgen (AMGN), AstraZeneca (AZN) to Present Brodalumab Data; Will Advance Into Phase 3
June 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8408658 for the full story. Read More
from StreetInsider.com News Articles
Is M&A Mania Poised to Keep Fanning the Market’s Flames?
June 12, 2013
 Read More
category NYSE:S , NASDAQ:GOOG , Market Outlook , and 3 more.
from InvestorPlace - Latest Headlines
Combining Therapies to Amplify the Effects of Statins
June 11, 2013
from ACCESSWIRE
PRESS DIGEST - British Business - June 11
June 10, 2013
June 11 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. Read More
category companyNews
from Reuters: Company News
Benzinga's M&A Chatter for Monday June 10, 2013
June 10, 2013
The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday June 10, 2013: Elan May Be Willing to Accept Cash Offer Of $15.50/Share The Rumor:Reuters reported Monday that... Read More
category AZN , Rumors , ELN , and 8 more.
from Latest Articles from Benzinga.com
AstraZeneca to Buy Pearl Therapeutics to Gain Lung Medicine
June 10, 2013
AstraZeneca agreed to buy Pearl Therapeutics, a closely held U.S. drugmaker, for as much as $1.15 billion to expand its portfolio of respiratory-disease treatments as competition for lung medicines... Read More
category AZN , Benzinga , News , and 1 more.
from Latest Articles from Benzinga.com
Notable Mergers and Acquisitions of the Day 06/10: (IHS) (AZN) (UBSH)/(STEL) (TRV) (GDOT)
June 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8402471 for the full story. Read More
from StreetInsider.com News Articles
Stocks Turn Lower Despite US Credit Outlook Upgrade
June 10, 2013
Stocks reversed their early gains Monday, despite an initial boost after S&P raised its rating on U.S. sovereign credit outlook. Read More
category ASTRAZENECA PLC , Apple Inc , Economics , and 17 more.
from CNBC.com News
US STOCKS SNAPSHOT-Wall St opens higher after credit outlook revised up
June 10, 2013
NEW YORK, June 10 (Reuters) - U.S. stocks rose on Monday after rating agency Standard & Poor's revised its U.S. credit outlook higher and as last week's employment report eased investor jitters that... Read More
category companyNews
from Reuters: Company News
Merger Monday: Who’s the Big Winner?
June 10, 2013
 Read More
category NASDAQ:GOOG , NYSE:AZN , NYSE:IHS , and 1 more.
from InvestorPlace - Latest Headlines
US STOCKS-Wall St set to rise after credit outlook revised up
June 10, 2013
* Japan shares soar after GDP up 4.1 pct in first quarter Read More
category companyNews
from Reuters: Company News
AstraZeneca to Acquire Pearl Therapeutics to Gain Foothold into Lucrative Market (AZN, GSK, NVS)
June 10, 2013
AstraZeneca (NYSE: AZN ) announced Monday that it will purchase privately held Pearl Therapeutics for up to $1.15 billion in its continuing drive to reinvigorate its product pipeline. The acquisition... Read More
category AZN , Benzinga , News , and 10 more.
from Latest Articles from Benzinga.com
US STOCKS-Futures rise after Japan data, market watches Fed
June 10, 2013
* Investors to mull Fed actions in wake of U.S. jobs report Read More
category companyNews
from Reuters: Company News
Early Movers: AAPL, ELAN, AZN, BAH & More
June 10, 2013
These are the stocks posting the largest moves before the bell. Read More
category CRM Holdings Ltd/ , ASTRAZENECA PLC , Walt Disney Co , and 30 more.
from CNBC.com News
AstraZeneca (AZN) to Acquire Pearl Therapeutics in $1.15B Deal
June 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8401445 for the full story. Read More
from StreetInsider.com News Articles
Stocks To Watch For June 10, 2013
June 10, 2013
Some of the stocks that may grab investor focus today are: Wall Street expects Lululemon Athletica (NASDAQ: LULU ) to post its Q1 earnings at $0.30 per share on revenue of $341.07 million. Lululemon... Read More
category Earnings , AZN , Benzinga , and 12 more.
from Latest Articles from Benzinga.com
UPDATE 1-AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 bln
June 10, 2013
* $560 mln upfront payment, further payouts on drug success Read More
category companyNews
from Reuters: Company News
AstraZeneca buys lung drug firm Pearl for up to $1.15 bln
June 10, 2013
LONDON, June 10 (Reuters) - AstraZeneca is to buy U.S. respiratory drug specialist Pearl Therapeutics for up to $1.15 billion as Britain's second biggest drugmaker steps up a drive to rebuild its... Read More
category companyNews
from Reuters: Company News
GSK, AZN, KERX, and RPTP Early Briefing and Review
June 07, 2013
from ACCESSWIRE
Stem-Cell Producer CDI Files to Go Public
June 07, 2013
 Read More
category NYSE:JPM , NYSE:GSK , NYSE:AZN , and 1 more.
from InvestorPlace - Latest Headlines
< Previous 1 2 3 4 5 6 7 8 9
...
72 73 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
2
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
TM Meyer
3
Why Apple Inc. Can't Be Forgiven for iOS 7
Mike Schuster
4
What Now, Mr. Bernanke? Traders Position Into the FOMC Rate Decision
Todd Harrison
5
In Insider Trading, Phillip Frost Increases Stake in Opko Health Inc. and Larry Page Sells Shares of Google Inc
Jonathan Moreland